One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-137743
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 30 |
Affiliation: Vrije Universiteit Amsterdam, Utrecht University, University Medical Center Utrecht, Mount Sinai Hospital, University College London Hospitals NHS Foundation Trust, University College London, Azienda Sanitaria Unità Locale di Reggio Emilia, Bristol-Myers Squibb (United States), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Vall d'Hebron Hospital Universitari, Dana-Farber Cancer Institute, Bristol-Myers Squibb (Switzerland), University of Michigan–Ann Arbor, Michigan Medicine, Erasmus MC, Hackensack University Medical Center, Emory University, Institut Català d'Oncologia, Mayo Clinic, Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Karmanos Cancer Institute, University of Maryland Medical Center, University of Maryland, Baltimore, University of PennsylvaniaFirst Results of Iberdomide (IBER; CC-220) in Combination with Dexamethasone (DEX) and Daratumumab (DARA) or Bortezomib (BORT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
